PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Veranews2024-06-25T17:02:37+00:00June 25th, 2024|Medical Device News Magazine|
